Here's the live share price of Mangalam Drugs and Organics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mangalam Drugs and Organics | -4.99 | 10.71 | 5.57 | 3.17 | -60.84 | -33.91 | -27.20 |
| Sun Pharmaceutical Industries | -1.10 | -3.11 | 6.72 | 8.55 | 20.01 | 19.65 | 19.36 |
| Divi's Laboratories | -1.82 | 8.71 | 37.99 | 44.45 | 48.31 | 35.81 | 11.82 |
| Torrent Pharmaceuticals | -3.67 | -3.58 | 11.81 | 11.70 | 34.86 | 38.43 | 25.38 |
| Zydus Lifesciences | -5.56 | 0.22 | 3.28 | 25.03 | 10.77 | 21.79 | 15.02 |
| Cipla | -2.33 | -4.48 | -0.91 | 5.51 | -12.21 | 3.79 | 7.82 |
| Laurus Labs | -4.92 | 0.25 | 28.92 | 78.60 | 110.67 | 67.07 | 22.74 |
| Lupin | -2.94 | -11.15 | -6.12 | -8.39 | 8.85 | 24.38 | 16.53 |
| Dr. Reddy's Laboratories | -2.02 | -0.57 | -8.92 | -10.62 | -7.93 | 0.64 | 3.26 |
| Mankind Pharma | -2.47 | -5.38 | -1.10 | 5.62 | -9.26 | 9.97 | 10.33 |
| Aurobindo Pharma | 0.20 | 4.39 | 12.96 | 38.34 | 59.70 | 26.36 | 16.97 |
| Glenmark Pharmaceuticals | -3.59 | 9.37 | 11.26 | 18.96 | 21.92 | 47.18 | 35.27 |
| Biocon | -3.44 | -6.56 | -4.44 | 5.02 | 11.31 | 15.01 | 1.91 |
| Alkem Laboratories | -3.06 | -5.70 | -1.70 | -5.03 | -2.22 | 12.43 | 6.28 |
| Abbott India | -0.66 | -6.19 | 1.11 | -6.10 | -18.87 | 5.35 | 5.90 |
| Anthem Biosciences | 3.26 | 13.61 | 24.74 | 39.49 | 10.19 | 8.39 | 4.95 |
| GlaxoSmithKline Pharmaceuticals | -4.60 | 11.93 | 36.77 | 19.37 | 4.32 | 27.64 | 14.60 |
| Ipca Laboratories | 0.73 | 16.81 | 21.30 | 33.12 | 46.83 | 30.68 | 9.48 |
| Gland Pharma | 1.61 | 13.62 | 32.04 | 71.54 | 55.38 | 19.73 | -5.98 |
| Ajanta Pharma | -2.66 | -1.64 | 17.53 | 18.80 | 33.18 | 26.31 | 18.64 |
Source: Dion Global
Over the last one year, Mangalam Drugs and Organics has declined 60.84% compared to peers like Sun Pharmaceutical Industries (20.01%), Divi's Laboratories (48.31%), Torrent Pharmaceuticals (34.86%). From a 5 year perspective, Mangalam Drugs and Organics has underperformed peers relative to Sun Pharmaceutical Industries (19.36%) and Divi's Laboratories (11.82%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 31.17 | 30.68 |
| 10 | 30.5 | 30.34 |
| 20 | 28.92 | 29.5 |
| 50 | 28.18 | 28.81 |
| 100 | 28.83 | 29.99 |
| 200 | 31.31 | 37.05 |
Source: Dion Global
In the latest quarter, Mangalam Drugs and Organics remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.11%, and public shareholding moved up to 64.24% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Aug 31, 2026, 11:30 PM IST IST | Mangalam Drugs - Reg. 34 (1) Annual Report. |
| Aug 31, 2026, 11:22 PM IST IST | Mangalam Drugs - Intimation Of 53Rd Annual General Meeting To Be Held On Wednesday, September 23Rd, 2026. |
| Aug 17, 2026, 10:10 PM IST IST | Mangalam Drugs - Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure |
| Aug 12, 2026, 11:30 PM IST IST | Mangalam Drugs - Appointment Of Secretarial Auditor Of The Company For Term Of 5 Years Subject To Approval Of Shareholders In |
| Aug 12, 2026, 11:15 PM IST IST | Mangalam Drugs - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s |
Source: Dion Global
Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 232.13 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mangalam Drugs and Organics is ₹30.30 as on Sep 04, 2026.
The Mangalam Drugs and Organics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Mangalam Drugs and Organics is ₹47.96 Cr as on Sep 04, 2026.
Today’s highest and lowest price of Mangalam Drugs and Organics are ₹31.16 and ₹29.87.
The 52-week high/low is the highest and lowest price at which Mangalam Drugs and Organics stock has traded in the past 52-week or nearly a year. The 52-week high of Mangalam Drugs and Organics is ₹85.99 and 52-week low of Mangalam Drugs and Organics is ₹22.70 as on Sep 04, 2026.
The Mangalam Drugs and Organics has shown returns of -0.59% over the past day, 10.71% for the past month, 5.57% over 3 months, -60.84% over 1 year, -33.91% across 3 years, and -27.2% over 5 years.
P/E ratio of and PB ratio of Mangalam Drugs and Organics are -1.25 and 0.50 on Sep 04, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global